RAYMOND DEBBANE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RAYMOND DEBBANE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RAYMOND DEBBANE. RAYMOND DEBBANE is Director in WEIGHT WATCHERS INTERNATIONAL INC ($WTW) and Director in LEXICON PHARMACEUTICALS, INC. ($LEXG) and Director in Blue Buffalo Pet Products, Inc. ($BUFF).
Latest Insider Trading Transactions of RAYMOND DEBBANE
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BUFF, LEXG, WTW
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 5.04 | 6,475 | 32,634 | 6,475 | |
May 03 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 0.00 | 4,024 | 0 | 4,024 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | M | 0.00 | 10,638 | 0 | 327,521 | 316.9 K to 327.5 K (+3.36 %) |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | M | 0.00 | 10,638 | 0 | 0 | |
Apr 27 2021 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | M | 0.00 | 10,638 | 0 | 327,521 | 316.9 K to 327.5 K (+3.36 %) |
Apr 07 2021 | WTW | WW INTERNATIONAL, ... | DEBBANE RAYMOND | Director | Grant | A | 30.77 | 609 | 18,739 | 39,595 | 39 K to 39.6 K (+1.56 %) |
Jan 06 2021 | WTW | WW INTERNATIONAL, ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 724 | 0 | 38,986 | 38.3 K to 39 K (+1.89 %) |
Sep 30 2020 | WTW | WW INTERNATIONAL, ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 996 | 0 | 38,262 | 37.3 K to 38.3 K (+2.67 %) |
Jul 01 2020 | WTW | WW INTERNATIONAL, ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 740 | 0 | 37,266 | 36.5 K to 37.3 K (+2.03 %) |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | M | 0.00 | 3,466 | 0 | 0 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 0.00 | 10,638 | 0 | 10,638 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 1.86 | 18,115 | 33,694 | 18,115 | |
Apr 27 2020 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | M | 0.00 | 3,466 | 0 | 316,883 | 313.4 K to 316.9 K (+1.11 %) |
Apr 01 2020 | WTW | WW INTERNATIONAL, ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,128 | 0 | 36,526 | 35.4 K to 36.5 K (+3.19 %) |
Jan 02 2020 | WTW | WW INTERNATIONAL, ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 469 | 0 | 35,398 | 34.9 K to 35.4 K (+1.34 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.80 | 3,400 | 9,520 | 313,417 | 310 K to 313.4 K (+1.10 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.79 | 7,500 | 20,925 | 310,017 | 302.5 K to 310 K (+2.48 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.78 | 3,900 | 10,842 | 302,517 | 298.6 K to 302.5 K (+1.31 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.77 | 12,400 | 34,348 | 298,617 | 286.2 K to 298.6 K (+4.33 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.76 | 4,500 | 12,420 | 286,217 | 281.7 K to 286.2 K (+1.60 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.75 | 6,853 | 18,846 | 281,717 | 274.9 K to 281.7 K (+2.49 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.74 | 1,900 | 5,206 | 274,864 | 273 K to 274.9 K (+0.70 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.73 | 11,100 | 30,303 | 272,964 | 261.9 K to 273 K (+4.24 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.72 | 8,082 | 21,983 | 261,864 | 253.8 K to 261.9 K (+3.18 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.71 | 6,443 | 17,461 | 253,782 | 247.3 K to 253.8 K (+2.60 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.70 | 400 | 1,080 | 247,339 | 246.9 K to 247.3 K (+0.16 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.69 | 500 | 1,345 | 246,939 | 246.4 K to 246.9 K (+0.20 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.68 | 1,300 | 3,484 | 246,439 | 245.1 K to 246.4 K (+0.53 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.67 | 4,600 | 12,282 | 245,139 | 240.5 K to 245.1 K (+1.91 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.66 | 1,100 | 2,926 | 240,539 | 239.4 K to 240.5 K (+0.46 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.64 | 2,100 | 5,544 | 239,439 | 237.3 K to 239.4 K (+0.88 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.63 | 4,800 | 12,624 | 237,339 | 232.5 K to 237.3 K (+2.06 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.62 | 3,110 | 8,148 | 232,539 | 229.4 K to 232.5 K (+1.36 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.61 | 5,795 | 15,125 | 229,429 | 223.6 K to 229.4 K (+2.59 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.60 | 3,990 | 10,374 | 223,634 | 219.6 K to 223.6 K (+1.82 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.47 | 400 | 988 | 219,644 | 219.2 K to 219.6 K (+0.18 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.46 | 8,869 | 21,818 | 219,244 | 210.4 K to 219.2 K (+4.22 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.46 | 100 | 246 | 210,375 | 210.3 K to 210.4 K (+0.05 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.45 | 3,800 | 9,310 | 210,275 | 206.5 K to 210.3 K (+1.84 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.45 | 100 | 245 | 206,475 | 206.4 K to 206.5 K (+0.05 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.44 | 29,880 | 72,907 | 206,375 | 176.5 K to 206.4 K (+16.93 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.44 | 1,700 | 4,140 | 176,495 | 174.8 K to 176.5 K (+0.97 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.43 | 18,051 | 43,864 | 174,795 | 156.7 K to 174.8 K (+11.52 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.43 | 900 | 2,183 | 156,744 | 155.8 K to 156.7 K (+0.58 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.42 | 15,582 | 37,708 | 155,844 | 140.3 K to 155.8 K (+11.11 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.42 | 200 | 483 | 140,262 | 140.1 K to 140.3 K (+0.14 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.41 | 24,772 | 59,701 | 140,062 | 115.3 K to 140.1 K (+21.49 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.40 | 34,087 | 81,809 | 115,290 | 81.2 K to 115.3 K (+41.98 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.40 | 152 | 365 | 81,203 | 81.1 K to 81.2 K (+0.19 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.40 | 1,200 | 2,874 | 81,051 | 79.9 K to 81.1 K (+1.50 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.39 | 21,652 | 51,748 | 79,851 | 58.2 K to 79.9 K (+37.20 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.38 | 28,225 | 67,176 | 58,199 | 30 K to 58.2 K (+94.16 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.38 | 400 | 950 | 29,974 | 29.6 K to 30 K (+1.35 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.37 | 5,494 | 13,021 | 29,574 | 24.1 K to 29.6 K (+22.82 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.36 | 2,068 | 4,880 | 24,080 | 22 K to 24.1 K (+9.39 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.36 | 200 | 471 | 22,012 | 21.8 K to 22 K (+0.92 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.35 | 1,700 | 3,995 | 21,812 | 20.1 K to 21.8 K (+8.45 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.34 | 1,101 | 2,576 | 20,112 | 19 K to 20.1 K (+5.79 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.33 | 1,300 | 3,029 | 19,011 | 17.7 K to 19 K (+7.34 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.32 | 2,309 | 5,357 | 17,711 | 15.4 K to 17.7 K (+14.99 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.31 | 500 | 1,155 | 15,402 | 14.9 K to 15.4 K (+3.36 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.30 | 800 | 1,840 | 14,902 | 14.1 K to 14.9 K (+5.67 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.29 | 300 | 687 | 14,102 | 13.8 K to 14.1 K (+2.17 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.28 | 300 | 684 | 13,802 | 13.5 K to 13.8 K (+2.22 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.27 | 400 | 908 | 13,502 | 13.1 K to 13.5 K (+3.05 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.25 | 200 | 450 | 13,102 | 12.9 K to 13.1 K (+1.55 %) |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 0.00 | 3,466 | 0 | 3,466 | |
Apr 29 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 5.67 | 6,519 | 36,963 | 6,519 | |
Apr 03 2019 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 942 | 0 | 33,426 | 32.5 K to 33.4 K (+2.90 %) |
Jan 04 2019 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 453 | 0 | 32,484 | 32 K to 32.5 K (+1.41 %) |
Dec 03 2018 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Gift | G | 0.00 | 43,125 | 0 | 32,031 | 75.2 K to 32 K (-57.38 %) |
Oct 03 2018 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 262 | 0 | 75,156 | 74.9 K to 75.2 K (+0.35 %) |
Sep 04 2018 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Gift | G | 0.00 | 40,000 | 0 | 74,894 | 114.9 K to 74.9 K (-34.81 %) |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 7.80 | 2,857 | 22,285 | 2,857 | |
Apr 27 2018 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 2,564 | 0 | 12,902 | 10.3 K to 12.9 K (+24.80 %) |
Apr 24 2018 | BUFF | Blue Buffalo Pet P ... | DEBBANE RAYMOND | Director | Sell | D | 0.00 | 10,569 | 0 | 0 | 10.6 K to 0 (-100.00 %) |
Apr 04 2018 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 295 | 0 | 114,707 | 114.4 K to 114.7 K (+0.26 %) |
Jan 04 2018 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 390 | 0 | 114,412 | 114 K to 114.4 K (+0.34 %) |
Oct 04 2017 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 435 | 0 | 114,022 | 113.6 K to 114 K (+0.38 %) |
Jul 06 2017 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 569 | 0 | 113,587 | 113 K to 113.6 K (+0.50 %) |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 15.61 | 2,857 | 44,598 | 2,857 | |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,281 | 0 | 10,338 | 9.1 K to 10.3 K (+14.14 %) |
Apr 05 2017 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,216 | 0 | 113,018 | 111.8 K to 113 K (+1.09 %) |
Jan 05 2017 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 804 | 0 | 111,802 | 111 K to 111.8 K (+0.72 %) |
Dec 19 2016 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,000 | 0 | 110,998 | 110 K to 111 K (+0.91 %) |
Oct 05 2016 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 904 | 0 | 109,998 | 109.1 K to 110 K (+0.83 %) |
Jul 07 2016 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 820 | 0 | 109,094 | 108.3 K to 109.1 K (+0.76 %) |
May 02 2016 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 13.96 | 2,857 | 39,884 | 2,857 | |
May 02 2016 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,432 | 0 | 9,057 | 7.6 K to 9.1 K (+18.78 %) |
Apr 06 2016 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 656 | 0 | 108,274 | 107.6 K to 108.3 K (+0.61 %) |
Apr 05 2016 | BUFF | Blue Buffalo Pet P ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 3,324 | 0 | 6,874 | 3.6 K to 6.9 K (+93.63 %) |
Mar 03 2016 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Buy | P | 12.03 | 83,125 | 1,000,168 | 107,618 | 24.5 K to 107.6 K (+339.38 %) |
Jan 06 2016 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 462 | 0 | 24,493 | 24 K to 24.5 K (+1.92 %) |
Dec 17 2015 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,000 | 0 | 24,031 | 23 K to 24 K (+4.34 %) |
Oct 07 2015 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,514 | 0 | 23,031 | 21.5 K to 23 K (+7.04 %) |
Jul 08 2015 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,977 | 0 | 21,517 | 19.5 K to 21.5 K (+10.12 %) |
Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 1.07 | 20,000 | 21,400 | 20,000 | |
Apr 24 2015 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 18,691 | 0 | 53,376 | 34.7 K to 53.4 K (+53.89 %) |
Apr 08 2015 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,313 | 0 | 19,540 | 18.2 K to 19.5 K (+7.20 %) |
Jul 07 2009 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 366 | 0 | 6,429 | 6.1 K to 6.4 K (+6.04 %) |
Jan 07 2009 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 28.53 | 328 | 9,358 | 5,572 | 5.2 K to 5.6 K (+6.25 %) |
Dec 17 2008 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,000 | 0 | 5,244 | 4.2 K to 5.2 K (+23.56 %) |
Sep 30 2008 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 37.07 | 252 | 9,342 | 4,244 | 4 K to 4.2 K (+6.31 %) |
Jul 01 2008 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 249 | 0 | 3,992 | 3.7 K to 4 K (+6.65 %) |
Apr 01 2008 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 199 | 0 | 3,743 | 3.5 K to 3.7 K (+5.62 %) |
Jan 03 2008 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 204 | 0 | 3,544 | 3.3 K to 3.5 K (+6.11 %) |
Dec 18 2007 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,000 | 0 | 3,340 | 2.3 K to 3.3 K (+42.74 %) |
Oct 02 2007 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 54.22 | 172 | 9,326 | 2,340 | 2.2 K to 2.3 K (+7.93 %) |
Jul 03 2007 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 50.48 | 185 | 9,339 | 2,168 | 2 K to 2.2 K (+9.33 %) |
Apr 03 2007 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 46.14 | 203 | 9,366 | 1,983 | 1.8 K to 2 K (+11.40 %) |
Jan 03 2007 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 52.12 | 359 | 18,711 | 1,780 | 1.4 K to 1.8 K (+25.26 %) |
Dec 15 2006 | WTW | WEIGHT WATCHERS IN ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,000 | 0 | 1,421 | 421 to 1.4 K (+237.53 %) |
Page: 1